Compare Hinge Health Inc. Class A Common Stock (HNGE) vs 3M Company (MMM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs 3M Company — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.47B), while 3M Company trades at $165 (market cap $84.82B). The key difference: 3M Company is far larger — about 10× Hinge Health Inc. Class A Common Stock's market cap, and 3M Company pays a 1.9% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and 3M Company for 169 Days on average.
| HNGE | MMM | |
|---|---|---|
Market Cap | $8.47B | $84.82B |
Volume | 1,624,526 | 2,697,631 |
Sector | Health | Industrials |
52-Week High | $105.14 | $183.79 |
52-Week Low | $31.17 | $141.10 |
Typical Hold Time | 0 Days | 169 Days |
Enterprise Value | $8.09B | $94.04B |
Dividend Yield | — | 1.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
3M (MMM) trades at $162.77, up 1.17% today, showing resilience amid a bearish technical signal. The company delivered three consecutive quarterly EPS beats, with Q2 2026 actual EPS of $2.40 beating the $2.25 estimate. Revenue for 2025 was $24.95B with a net income margin of 11.9%, though down from 2024's 16.98%. Analyst consensus is split evenly between Buy and Hold ratings, with a $191.00 price target suggesting 17% upside. Recent news highlights operational improvements and litigation management progress.
The outlook for MMM is cautiously optimistic, supported by strong earnings performance and strategic initiatives, but weighed by high debt levels and mixed technical indicators. Investment opportunity lies in continued execution on margin expansion and growth in industrial segments, while risks include consumer segment weakness and macroeconomic pressures. The stock's current valuation at a P/E of 28.91 requires sustained earnings growth to justify further appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →
